News - Helix Surgical

World premiere of the new Rx

World premiere of the new Rx at ESCRS 2026 𝟭𝟭–𝟭𝟱 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 at 𝗘𝘅c𝗲𝗟 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗨𝗞.

First capsulorhexis-fixated with Teleon IOL : Femtis

Helix team members interviews

Helix Surgical Appoints Florent Deloison as President and CEO to Lead the Commercial Launch Phase of the Rx Femtolaser

We are excited to announce our participation at the ESCRS Congress 2025 in Copenhaguen! Booth #E218

Dr Lignereux compared capsulotomy method's impacts on patient flow. The 3rd Gen Handheld femto is a game changer.

We had the pleasure of attending the prestigious ESCRS congress, held this year in Barcelona.

We are excited to announce our participation at the ESCRS Congress in Barcelona!

Helix Surgical has the privilege to participate in the AECOS (American-European Congress of Ophtalmic Surgery), in Prague (06-9 June 2024).

Dr. Lignereux, Institut Ophtalmologique Sourdille Atlantique, Nantes, France, participated in the clinical trial from February 2022 to March 2023.

An other exciting event for Helix Surgical. The ASCRS (American Society of Cataract and Refractive surgery) Congress (April 5-8, 2024)

December 12th, 2023 – We are delighted to announce a significant milestone at Helix Surgical. Our Rx has achieved CE

Professor of Ophthalmology at the Bordeaux University Hospital, head of the anterior segment unit. Science Phd in “laser surgery of